Alto Neuroscience is a precision psychiatry company that leverages advanced neuroscience research and clinical data to match patients with neuropsychiatric conditions to the most effective, personalized treatments. Founded by Dr. Amit Etkin, Alto's platform applies data-driven methods and machine learning to revolutionize psychiatric drug development and enhance patient care through individualized therapeutic recommendations. Their solutions are designed for clinicians, researchers, and healthcare organizations seeking precision medicine and evidence-based approaches for mental health.
Visit Alto Neuroscience's official website for product details and getting started.